A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression

BACKGROUND: In a recent clinical trial examining the comparative efficacy of psilocybin therapy (PT) versus escitalopram treatment (ET) for major depressive disorder, 14 of 16 major efficacy outcome measures yielded results that favored PT, but the Quick Inventory of Depressive Symptomatology, Self-...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Brandon, Erritzoe, David, Giribaldi, Bruna, Nutt, David J, Carhart-Harris, Robin L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350722/
https://www.ncbi.nlm.nih.gov/pubmed/37122239
http://dx.doi.org/10.1177/02698811231167848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350722/
https://www.ncbi.nlm.nih.gov/pubmed/37122239
http://dx.doi.org/10.1177/02698811231167848

Ejemplares similares